Jennifer J Rhodes - Net Worth and Insider Trading
Jennifer J Rhodes Net Worth
The estimated net worth of Jennifer J Rhodes is at least $2 Million dollars as of 2024-04-25. Jennifer J Rhodes is the GC & Corporate Secretary of Medivation Inc and owns about 22,180 shares of Medivation Inc (MDVN) stock worth over $2 Million. Jennifer J Rhodes is the CBO, GC & Compliance Officer of Adamas Pharmaceuticals Inc and owns about 63,114 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $518,797. Jennifer J Rhodes is also the See Remarks of Angion Biomedica Corp and owns about 3,040 shares of Angion Biomedica Corp (ANGN) stock worth over $30,400. Details can be seen in Jennifer J Rhodes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer J Rhodes has not made any transactions after 2021-12-14 and currently still holds the listed stock(s).
Transaction Summary of Jennifer J Rhodes
Jennifer J Rhodes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer J Rhodes owns 4 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Medivation Inc (MDVN) , and Angion Biomedica Corp (ANGN) among others .
Click here to see the complete history of Jennifer J Rhodes’s form 4 insider trades.
Insider Ownership Summary of Jennifer J Rhodes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2019-06-20 | CBO & GC & Compliance Officer |
| MDVN | Medivation Inc | 2015-03-16 | GC & Corporate Secretary |
| ANGN | Angion Biomedica Corp | 2021-12-14 | See Remarks |
| ELTX | Elicio Therapeutics Inc | 2021-02-04 | See Remarks |
Jennifer J Rhodes Latest Holdings Summary
Jennifer J Rhodes currently owns a total of 3 stocks. Among these stocks, Jennifer J Rhodes owns 22,180 shares of Medivation Inc (MDVN) as of March 16, 2015, with a value of $2 Million and a weighting of 76.68%. Jennifer J Rhodes owns 63,114 shares of Adamas Pharmaceuticals Inc (ADMS) as of June 20, 2019, with a value of $518,797 and a weighting of 22.02%. Jennifer J Rhodes also owns 3,040 shares of Angion Biomedica Corp (ANGN) as of December 14, 2021, with a value of $30,400 and a weighting of 1.29%.
Latest Holdings of Jennifer J Rhodes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDVN | Medivation Inc | 2015-03-16 | 22,180 | 81.44 | 1,806,339 |
| ADMS | Adamas Pharmaceuticals Inc | 2019-06-20 | 63,114 | 8.22 | 518,797 |
| ANGN | Angion Biomedica Corp | 2021-12-14 | 3,040 | 10.00 | 30,400 |
Holding Weightings of Jennifer J Rhodes
Jennifer J Rhodes Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer J Rhodes has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 2,780 shares on March 16, 2015, which brought Jennifer J Rhodes around $181,979.
According to the SEC Form 4 filings, Jennifer J Rhodes has made a total of 1 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 940 shares on June 20, 2019, which brought Jennifer J Rhodes around $5,029.
According to the SEC Form 4 filings, Jennifer J Rhodes has made a total of 11 transactions in Angion Biomedica Corp (ANGN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Angion Biomedica Corp is the sale of 45 shares on December 14, 2021, which brought Jennifer J Rhodes around $1,091.
Insider Trading History of Jennifer J Rhodes
- 1
Jennifer J Rhodes Trading Performance
Jennifer J Rhodes Ownership Network
Ownership Network List of Jennifer J Rhodes
Ownership Network Relation of Jennifer J Rhodes
Jennifer J Rhodes Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
Jennifer J Rhodes is the CBO & GC & Compliance Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
Jennifer J Rhodes Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer J Rhodes. You might contact Jennifer J Rhodes via mailing address: C/o Adamas Pharmaceuticals Inc., 1900 Powell St., Suite 750, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
